Table 1.

The AGREE criteria

Scope and purpose
    1. The overall objective(s) of the guideline is (are) specifically described.
    2. The clinical question(s) covered by the guideline is (are) specifically described.
    3. The patients to whom the guideline is meant to apply are specifically described.
Stakeholder involvement
    4. The guideline development group includes individuals from all the relevant professional groups.
    5. The patients' views and preferences have been sought.
    6. The target users of the guideline are clearly defined.
    7. The guideline has been piloted among target users.
Rigor of development
    8. Systematic methods were used to search for evidence.
    9. The criteria for selecting the evidence are clearly described.
    10. The methods used for formulating the recommendations are clearly described.
    11. The health benefits, side effects, and risks have been considered in formulating the recommendations.
    12. There is an explicit link between the recommendations and the supporting evidence.
    13. The guideline has been externally reviewed by experts before its publication.
    14. A procedure for updating the guideline is provided.
Clarity and presentation
    15. The recommendations are specific and unambiguous.
    16. The different options for management of the condition are clearly presented.
    17. Key recommendations are easily identifiable.
    18. The guideline is supported with tools for application.
    19. The potential organizational barriers in applying the recommendations have been discussed.
    20. The potential cost implications of applying the recommendations have been considered.
    21. The guideline presents key review criteria for monitoring and/or audit purposes.
Editorial independence
    22. The guideline is editorially independent from the funding body.
    23. Conflicts of interest of guideline development members have been recorded.